Phase II Study of Bendamustine in Relapsed and Refractory Hodgkin Lymphoma

PURPOSE: Limited data exist regarding the activity of bendamustine in Hodgkin lymphoma (HL). This phase II study evaluated the efficacy of bendamustine in relapsed and refractory HL. PATIENTS AND METHODS: Patients with relapsed and refractory HL who were ineligible for autologous stem-cell transplan...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Moskowitz, Alison J., Hamlin, Paul A., Perales, Miguel-Angel, Gerecitano, John, Horwitz, Steven M., Matasar, Matthew J., Noy, Ariela, Palomba, Maria Lia, Portlock, Carol S., Straus, David J., Graustein, Tricia, Zelenetz, Andrew D., Moskowitz, Craig H.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2013
Teme:
Original Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3862960/
https://ncbi.nlm.nih.gov/pubmed/23248254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.45.3308
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items